Avricore Health Stock Beneish M Score

AVCR Stock  CAD 0.04  0.01  10.00%   
This module uses fundamental data of Avricore Health to approximate the value of its Beneish M Score. Avricore Health M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avricore Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
  
At this time, Avricore Health's Debt To Equity is fairly stable compared to the past year. Debt Equity Ratio is likely to climb to 0.02 in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 34.2 K in 2025. At this time, Avricore Health's Capex To Operating Cash Flow is fairly stable compared to the past year. EV To Operating Cash Flow is likely to climb to 30.51 in 2025, whereas Days Sales Outstanding is likely to drop 48.94 in 2025.
At this time, Avricore Health's M Score is inapplicable. The earnings manipulation may begin if Avricore Health's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Avricore Health executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Avricore Health's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-3.63
Beneish M Score - Inapplicable
Elasticity of Receivables

1.0

Focus
Asset Quality

0.92

Focus
Expense Coverage

0.53

Focus
Gross Margin Strengs

0.84

Focus
Accruals Factor

0.53

Focus
Depreciation Resistance

0.85

Focus
Net Sales Growth

1.05

Focus
Financial Leverage Condition

-1.54

Focus

Avricore Health Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Avricore Health's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables508.4 K484.1 K
Sufficiently Up
Slightly volatile
Total Revenue4.2 MM
Sufficiently Up
Slightly volatile
Total Assets3.1 M2.9 M
Sufficiently Up
Slightly volatile
Total Current Assets1.1 M889.6 K
Significantly Up
Very volatile
Non Current Assets Total2.1 MM
Sufficiently Up
Slightly volatile
Property Plant Equipment59.8 K104.5 K
Way Down
Slightly volatile
Depreciation And Amortization221 K210.5 K
Sufficiently Up
Slightly volatile
Selling General Administrative1.2 M2.1 M
Way Down
Slightly volatile
Total Current Liabilities409.8 K608.6 K
Way Down
Pretty Stable
Short Term Debt34.2 K36 K
Notably Down
Pretty Stable
Short Term Investments8.6 KK
Notably Down
Slightly volatile

Avricore Health Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Avricore Health's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Avricore Health in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Avricore Health's degree of accounting gimmicks and manipulations.

About Avricore Health Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Depreciation And Amortization

221,029

At this time, Avricore Health's Depreciation And Amortization is fairly stable compared to the past year.

Avricore Health Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Avricore Health. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
202020212022202320242025 (projected)
Net Receivables11.9K91.5K770.4K421.0K484.1K508.4K
Total Revenue33.0K122.8K1.8M3.5M4.0M4.2M
Total Assets440.1K2.3M2.6M2.5M2.9M3.1M
Total Current Assets440.1K2.2M1.4M773.6K889.6K1.1M
Net Debt7.6K698.8K(2.0M)(580.5K)(522.5K)(548.6K)
Operating Income(859.2K)(1.7M)(809.9K)(687.2K)(618.5K)(649.4K)
Investments(4.3K)(140.4K)(1.2M)(1.0M)(942.2K)(895.1K)
Gross Profit Margin0.440.530.250.260.350.31

About Avricore Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Avricore Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avricore Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avricore Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Avricore Stock Analysis

When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.